Why JPM16 matters? Its all about perspective.

You might not realize it but the most important week in biotech is only hours away. There are a few things you should know if you are interested in following news and updates. First, things first. What is the JP Morgan Healthcare Conference (JPM)?

You may be surprised to hear that it is the biggest event you likely never heard of--the Superbowl of biotech. Don't bother navigating over to the website, there isn't one. Think of it like fight club. In fact that is a good reference, recall the first rule of fight club?

Tiny bars, restaurants, hotels, all become pop-up meeting rooms where deals made on the periphery often influence industry across the world.

The actual event is invite-only with coveted tickets to prove it. Bankers, investors, executives, companies and researchers gather from across the globe for arguably the most influential biotech conference of the year-- setting the tone for the entire year.

​If you find yourself without a ticket you may have better luck getting into impromptu meetings occuring nearby the Westin St Francis Hotel, perched on the edge of Union Square.

Here are a few highlights already speculating across social media. If you don't think the business of healthcare matters to a writer or leader in healthcare communications--tune in and be prepared to be wrong. Understanding the economics of biotech and medicine empowers you to be a better journalist and a more analytical writer. 

It never hurts to have a travel guide. Because remember--as with most conferences--it matters who you meet--not where you meet them.

Thoughtful discussions about content development and outcomes analytics that apply the principles and frameworks of health policy and economics to persistent and perplexing health and health care problems.

Share the story or sign-up for newsletter in the side-bar. Follow updates from conference here and on twitter @graphemeconsult